Skip to content
naulon

Corrected on Apr 27, 2020.

Source: the publisher, via Crossref · checked Oct 31, 2026 · Read the notice

  • Corrected on Mar 21, 2023. Source: the publisher, via Crossref · Read the notice
  • Corrected on Feb 11, 2020. Source: the publisher, via Crossref · Read the notice

Comprehensive molecular characterization of mitochondrial genomes in human cancers

Yuan Yuan, Young Seok Ju, Youngwook Kim and 97 more

Nature Genetics · 2020 · CC BY

doi:10.1101/161356

Abstract

Mitochondria are essential cellular organelles that play critical roles in cancer. Here, as part of the International Cancer Genome Consortium/The Cancer Genome Atlas Pan-Cancer Analysis of Whole Genomes Consortium, which aggregated whole-genome sequencing data from 2,658 cancers across 38 tumor types, we performed a multidimensional, integrated characterization of mitochondrial genomes and related RNA sequencing data. Our analysis presents the most definitive mutational landscape of mitochondrial genomes and identifies several hypermutated cases. Truncating mutations are markedly enriched in kidney, colorectal and thyroid cancers, suggesting oncogenic effects with the activation of signaling pathways. We find frequent somatic nuclear transfers of mitochondrial DNA, some of which disrupt therapeutic target genes. Mitochondrial copy number varies greatly within and across cancers and correlates with clinical variables. Co-expression analysis highlights the function of mitochondrial genes in oxidative phosphorylation, DNA repair and the cell cycle, and shows their connections with clinically actionable genes. Our study lays a foundation for translating mitochondrial biology into clinical applications.

References 54

  1. 1.

    Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat. Rev. Genet. 2012;13:878-890.

    Not in our library10.1038/nrg3275

  2. 2.

    Smeitink J, van den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2001;2:342-352.

    Not in our library10.1038/35072063

  3. 3.

    Anderson S, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457-465.

    Not in our library10.1038/290457a0

  4. 4.

    Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene. 2006;25:4647-4662.

    Not in our library10.1038/sj.onc.1209607

  5. 5.

    Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol. Cell. 2016;61:667-676.

    Not in our library10.1016/j.molcel.2016.02.011

  6. 6.

    Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674.

    Not in our library10.1016/j.cell.2011.02.013

  7. 7.

    Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770-776.

    Not in our library10.1038/35037710

  8. 8.

    Larman TC, et al. Spectrum of somatic mitochondrial mutations in five cancers. Proc. Natl Acad. Sci. USA. 2012;109:14087-14091.

    Not in our library10.1073/pnas.1211502109

  9. 9.
  10. 10.

    Stewart JB, et al. Simultaneous DNA and RNA mapping of somatic mitochondrial mutations across diverse human cancers. PLoS Genet. 2015;11:e1005333.

    Not in our library10.1371/journal.pgen.1005333

  11. 11.

    Ju YS, et al. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res. 2015;25:814-824.

    Not in our library10.1101/gr.190470.115

  12. 12.
  13. 13.

    Hopkins JF, et al. Mitochondrial mutations drive prostate cancer aggression. Nat. Commun. 2017;8:656.

    Not in our library10.1038/s41467-017-00377-y

  14. 14.
  15. 15.

    The Cancer Genome Atlas Research Network et al. The Cancer Genome Atlas pan-cancer analysis project. Nat. Genet.45, 1113–1120 (2013).

    Not in our library10.1038/ng.2764

  16. 16.
  17. 17.
  18. 18.
  19. 19.

    Costello M, et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 2013;41:e67.

    Not in our library10.1093/nar/gks1443

  20. 20.

    Lawrence MS, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214-218.

    Not in our library10.1038/nature12213

  21. 21.
  22. 22.

    Tanaka M, Ozawa T. Strand asymmetry in human mitochondrial DNA mutations. Genomics. 1994;22:327-335.

    Not in our library10.1006/geno.1994.1391

  23. 23.

    Zheng W, Khrapko K, Coller HA, Thilly WG, Copeland WC. Origins of human mitochondrial point mutations as DNA polymerase γ-mediated errors. Mutat. Res. 2006;599:11-20.

    Not in our library10.1016/j.mrfmmm.2005.12.012

  24. 24.

    Alexandrov LB, et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 2015;47:1402-1407.

    Not in our library10.1038/ng.3441

  25. 25.

    Coller HA, et al. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat. Genet. 2001;28:147-150.

    Not in our library10.1038/88859

  26. 26.

    The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330-337.

    Not in our library10.1038/nature11252

  27. 27.

    The Cancer Genome Atlas Research Network et al. Integrated genomic characterization of endometrial carcinoma. Nature497, 67–73 (2013).

    Not in our library10.1038/nature12113

  28. 28.
  29. 29.

    Pak JW, Vang F, Johnson C, McKenzie D, Aiken JM. MtDNA point mutations are associated with deletion mutations in aged rat. Exp. Gerontol. 2005;40:209-218.

    Not in our library10.1016/j.exger.2004.12.005

  30. 30.

    Davis CF, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26:319-330.

    Not in our library10.1016/j.ccr.2014.07.014

  31. 31.

    Caro P, et al. Mitochondrial DNA sequences are present inside nuclear DNA in rat tissues and increase with age. Mitochondrion. 2010;10:479-486.

    Not in our library10.1016/j.mito.2010.05.004

  32. 32.
  33. 33.

    Srinivasainagendra V, et al. Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma. Genome Med. 2017;9:31.

    Not in our library10.1186/s13073-017-0420-6

  34. 34.

    Cui H, et al. Association of decreased mitochondrial DNA content with the progression of colorectal cancer. BMC Cancer. 2013;13:110.

    Not in our library10.1186/1471-2407-13-110

  35. 35.
  36. 36.

    Van Osch FH, et al. Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival. Carcinogenesis. 2015;36:1502-1510.

    Not in our library10.1093/carcin/bgv151

  37. 37.

    McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr. Biol. 2006;16:R551-R560.

    Not in our library10.1016/j.cub.2006.06.054

  38. 38.

    Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166:555-566.

    Not in our library10.1016/j.cell.2016.07.002

  39. 39.

    Lott MT, et al. mtDNA variation and analysis using mitomap and mitomaster. Curr. Protoc. Bioinformatics. 2013;44:1.23.1-1.23.26.

    Not in our library10.1002/0471250953.bi0123s44

  40. 40.

    Mercer TR, et al. The human mitochondrial transcriptome. Cell. 2011;146:645-658.

    Not in our library10.1016/j.cell.2011.06.051

All 54 references

Cited by papers we hold 10

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.